In most patients with NSCLC, proto-oncogenes, such as KRAS (Kirsten rat sarcoma viral oncogene homolog), and the AKT (also named PKB, protein kinase B) and ERK (extracellular signal-regulated kinase) signaling pathways are constitutionally activated. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.